|
1401 |
Neue S3-Leitlinie PAVK: Evidenz oft eher schwach
Enthalten in Cardiovasc Bd. 17, 31.3.2017, Nr. 2, date:4.2017: 24
|
|
|
|
1402 |
New clinical trials regulation in Spain: analysis of royal decree 1090/2015
Enthalten in Clinical and translational oncology Bd. 19, 7.10.2016, Nr. 3, date:3.2017: 291-300
|
|
|
|
1403 |
New electronic ADR reporting system in Tanzania
Enthalten in Reactions weekly Bd. 1642, 11.3.2017, Nr. 1, date:3.2017: 4
|
|
|
|
1404 |
New online ADR reporting system launched in Italy
Enthalten in Reactions weekly Bd. 1648, 22.4.2017, Nr. 1, date:4.2017: 5
|
|
|
|
1405 |
Nicht immer nach sechs Monaten stoppen!
Enthalten in MMW - Fortschritte der Medizin Bd. 159, 27.6.2017, Nr. 12, date:6.2017: 70
|
|
|
|
1406 |
Omalizumab: arterial thrombolic event rate not increased
Enthalten in Reactions weekly Bd. 1637, 4.2.2017, Nr. 1, date:2.2017: 10
|
|
|
|
1407 |
On the physical nature of “cytotropism” and allied phenomena and their bearing on the physics of organic form
Enthalten in Protoplasma Bd. 16, 1.12.1932, Nr. 1, date:12.1932: 343
|
|
|
|
1408 |
On Your Feet to Earn Your Seat: pilot RCT of a theory-based sedentary behaviour reduction intervention for older adults
Enthalten in Pilot and feasibility studies Bd. 3, 8.5.2017, Nr. 1, date:12.2017: 1-14
|
|
|
|
1409 |
Online versus in-person comparison of Microscale Audit of Pedestrian Streetscapes (MAPS) assessments: reliability of alternate methods
Enthalten in International journal of health geographics Bd. 16, 4.8.2017, Nr. 1, date:12.2017: 1-13
|
|
|
|
1410 |
Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial
Enthalten in Trials Bd. 18, 25.5.2017, Nr. 1, date:12.2017: 1-15
|
|
Administration
